SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001516551-21-000025
Filing Date
2021-12-16
Accepted
2021-12-16 18:50:43
Documents
3
Period of Report
2021-12-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163969862196316.html 4  
1 FORM 4 wf-form4_163969862196316.xml 4 3986
2 211214 KEITH WARD POA a211215_kwxskyexbiox-xpo.htm EX-24 3709
3 211214 KEITH WARD POA a211215_kwxskyexbiox-xpo001.jpg GRAPHIC 246203
  Complete submission text file 0001516551-21-000025.txt   348555
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Issuer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11217 JONAS RIDGE LANE RALEIGH NC 27613
Business Address
Ward Keith Wayne (Reporting) CIK: 0001662394 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55136 | Film No.: 211499112